王文首博士获中国科学院高分子化学专业博士学位，曾在南密西西比大学和明尼苏达大学从事药物递送研究，在多领域应用AI技术具有丰富经验，如3D打印、材料合成研究和药物递送等。目前，王文首博士引领剂泰医药进行AI驱动药物制剂和递送平台的研发，并负责企业日常运营。

王文首博士曾创办Inkbit，一家AI驱动的3D打印公司，可高精度打印最终使用的部件，且打印过程可重复性很高。在此之前，其以研究科学家的身份加入麻省理工学院计算机科学和人工智能实验室，创建了第一台运用机器视觉和机器学习技术的3D打印机。四年后，Inkbit实现了该项目技术的商业化。

He obtained his Ph.D. in polymer chemistry from the Chinese Academy of Sciences, and had been engaged in drug delivery research at the University of Southern Mississippi and the University of Minnesota. He has extensive experiences in applying AI technology in a wide range of fields, for instance, 3D printing, material synthesis research, and drug delivery. At present, Dr. Wang is leading the development of AI-driven drug formulation and drug delivery platforms, and in charge of the company’s daily operations in China.  

Dr. Wang was a research scientist at the MIT Computer Science and Artificial Intelligence Laboratory, where he created first ever 3D printer with machine vision and machine learning techniques. Subsequently he co-founded Inkbit, an AI-driven 3D printing company providing technology that can print end-use parts with high precision and high repeatability. Four years later, the technology at Inkbit was successfully commercialized.